Neuburgh Advisers’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $16.5M | Buy |
325,380
+101,116
| +45% | +$5.13M | 0.51% | 37 |
|
|
2019
Q2 | $10.2M | Buy |
224,264
+168,708
| +304% | +$7.65M | 0.33% | 69 |
|
|
2019
Q1 | $2.65M | Buy |
55,556
+22,984
| +71% | +$1.1M | 0.09% | 185 |
|
|
2018
Q4 | $1.69M | Sell |
32,572
-4,556
| -12% | -$237K | 0.07% | 214 |
|
|
2018
Q3 | $2.31M | Sell |
37,128
-578
| -2% | -$35.9K | 0.07% | 199 |
|
|
2018
Q2 | $2.09M | Sell |
37,706
-7,242
| -16% | -$401K | 0.07% | 210 |
|
|
2018
Q1 | $2.84M | Buy |
44,948
+7,242
| +19% | +$458K | 0.1% | 172 |
|
|
2017
Q4 | $2.31M | Buy |
37,706
+17,578
| +87% | +$1.08M | 0.08% | 184 |
|
|
2017
Q3 | $1.28M | Buy |
+20,128
| New | +$1.28M | 0.05% | 240 |
|
|
2017
Q1 | – | Sell |
-21,624
| Closed | -$1.26M | – | 883 |
|
|
2016
Q4 | $1.26M | Buy |
+21,624
| New | +$1.26M | 0.06% | 209 |
|